Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 7/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38660021 | 1.00 | MAOB (0.47) | MAOBKMT2ACYP1A2MAPTGAA | |
| SCHEMBL30426879 | 0.89 | MAOB (0.40) | MAOBKMT2ACYP1A2MAPTGAA | |
| SCHEMBL29706426 | 0.88 | GABRG2 (0.40) | MAOBKMT2ACYP1A2GAAALDH1A1 | |
| SCHEMBL31097882 | 0.87 | MAOB (0.44) | MAOBKMT2ACYP1A2MAPTGAA | |
| SCHEMBL6677730 | 0.85 | ENPP2 (0.41) | KMT2AMAPTGAAALDH1A1LMNA | |
| SCHEMBL29706586 | 0.78 | MCL1 (0.42) | KMT2ACYP1A2MAPTGAAALDH1A1 | |
| SCHEMBL1302549 | 0.77 | CYP3A4 (0.48) | ALDH1A1LMNACYP2C9TSHR | |
| SCHEMBL6206276 | 0.76 | — | — | |
| SCHEMBL1676924 | 0.76 | ENPP2 (0.59) | MAOBCYP1A2ALDH1A1LMNACYP2C9 | |
| SCHEMBL1941958 | 0.76 | ALDH1A1 (0.54) | MAOBKMT2AMAPTGAARECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122008677-A | High-wear-resistance veneer and preparation process thereof | 山东东宇鸿翔柜橱材料有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-120058757-A | Synthesis method of methyl iminodiacetic acid borate compound | 上海泰坦科技股份有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-119390951-A | Imino conjugated microporous polymer with high specific surface area and high conjugation degree and preparation method and application thereof | 东华大学 | 2025-02-07 | — | — | CN | claimed |
| CN-119368155-A | Fluorescent boron quantum dot photocatalyst and preparation method and application thereof | 南京工业大学 | 2025-01-28 | — | — | CN | claimed |
| CN-113511970-B | Synthesis method of aryl substituted alkyne | 杭州师范大学 | 2024-04-09 | — | — | CN | claimed |
| CN-117797651-A | Preparation method and separation application of charge reversible pore-balancing membrane | 浙江工业大学 | 2024-04-02 | — | — | CN | claimed |
| CN-114106058-B | Preparation method and application of aggregation-induced emission platinum complex | 大连理工大学 | 2023-09-12 | — | — | CN | claimed |
| CN-122008677-A | High-wear-resistance veneer and preparation process thereof | 山东东宇鸿翔柜橱材料有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-4637754-A2 | SELECTIVE BET INHIBITORS AND USES THEREOF | Tay Therapeutics Limited (GB) | 2025-10-29 | — | — | EP | disclosed |
| CN-120058757-A | Synthesis method of methyl iminodiacetic acid borate compound | 上海泰坦科技股份有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-120005686-A | Composition comprising lipase and sulfite | 诺维信公司 | 2025-05-16 | — | — | CN | disclosed |
| WO-2025067239-A1 | KINESIN KIF18A INHIBITOR, AND APPLICATION THEREOF | 上海湃隆生物科技有限公司 | 2025-04-03 | — | — | WO | disclosed |
| CN-116143716-B | Novel compound, material for organic electroluminescent element, and organic electroluminescent element | 出光兴产株式会社 | 2025-03-28 | — | — | CN | disclosed |
| US-6455720-B1 | AS CATALYSTS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-09-24 | — | — | US | disclosed |
| US-20020058837-A1 | 2,2 (Diarlyl) Vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2002-05-16 | — | — | US | disclosed |
| EP-1167372-A1 | 2,2-(Diaryl)vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | Takasago International Corporation (JP) | 2002-01-02 | — | — | EP | disclosed |
| EP-1137641-A1 | PROCESS FOR PREPARING PYRIDAZIN-3-ON DERIVATIVES | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2001-10-04 | — | — | EP | disclosed |
| US-6281214-B1 | USEFUL FOR TREATING AND AMELIORATING MENTAL DISORDERS | EISAI CO., LTD (JP) | 2001-08-28 | — | — | US | disclosed |
| WO-2000034249-A1 | PROCESS FOR PREPARING PYRIDAZIN-3-ON DERIVATIVES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2000-06-15 | — | — | WO | disclosed |
| EP-0675118-A2 | Biphenylderivatives, process for their preparation and their use as medicaments | Eisai Co., Ltd. (JP) | 1995-10-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058837-A1 | 2,2 (Diarlyl) Vinylphosphine compound, palladium catalyst thereof, and process for producing arylamine, diaryl, or arylalkyne with the catalyst | DDT, PDCD11, PLD2 | MAOB 2256/4885KMT2A 170/4885CYP1A2 1237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.